<html xmlns="http://www.w3.org/1999/xhtml"><head> <style type="text/css">
         	     		 
         	    a                          {background : #ffffff; }
         	    article                    {border-style : dotted; border-width : 2px; }
         		 	
         		 	div                        {background : #ffffcc;}
         		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
         		 	div.ack                    {border-style : solid ; border-color : red; margin
         : 2em; }
         		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin
         1em;}
         		 	div.boxed-text             {margin : 5em; border-style : solid;}
         		 	div.contrib-group          {margin : 1em; }
         		 	div.fig                    {border-style : solid; border-width : 2px; margin :
         2em; }
         		 	div.funding                {font-weight : bold ; font-size : 16pt;}
         		 	div.given-names            {font-style : italic;}
         		 	div.intro                  {border-style : inset; margin : 5px;}
         		 	div.introduction           {border-style : inset; margin : 5px;}
         		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin
         1em;}
         		 	div.journal-title-group    {background : #ffeeee;}
         		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
         		 	div.kwd                    {font-style : italic}
         		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
         		 	div.name                   {font-weight : bold;}
         		 	div.alt-title              {font-style : italic; font-size : 12px;}
         		 	
         		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
         		 	div.title                  {font-family : courier; font-weight : bold;
         		 	                            font-size : 16pt; margin : 5px;}
         		 	
         		 	div.materials_methods      {border-style : double; margin : 5px; }
         		 	div.methods                {border-style : double; margin : 5px; }
         		 	
         		 	div.results                {border-style : solid; margin : 5px;}
         		 	div.background             {border-style : dotted; margin : 5px;}
         		 	
         		 	div.discussion             {border-style : groove; margin : 5px;}
         		 	div.conclusion             {border-style : ridge; margin : 5px;}
         		 	div.conclusions             {border-style : ridge; margin : 5px;}
         		 	div.supplementary-material {border-style : inset; margin : 5px;}
         		 	div.abbreviations          {border-style : double; border-color : red; margin
         : 5px;}
         		 	div.competinginterests     {border-style : double; border-color : blue; margin
         : 5px;}
         		 	div.acknowledgements       {border-style : double; border-color : green; margin
         : 5px;}
         		 	div.authors_contributions   {border-style : double; border-color : purple; margin
         : 5px;}
         		 	
         		 	div.publisher              {border-style : outset; margin : 5px;}
         		 	div.fn-type-conflict       {background : #f88; }
         		 	div.fn-type-con            {background : #ddf; }
         		 	div.fn-type-other          {background : #ddd; }
         		 	
         		 	div.unknown                {background : #ffd;
         									 	  border-style : solid;
         									 	  border-width : 1px;
         									 	  padding : 2 px;}
         		 	  
         	    table                      {background : #ffffdd;}
         		 	tr                         {background : #ddddff; padding : 1px;}
         		 	
         		 	span                       {background : #ffcccc;}
         		 	
         		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
         		 	span.collab                {background : #ddffff; }
         		 	span.comment               {font-family : courier; font-size : 6px; background
         : #ffaaff;}
         		 	span.contrib               {background : #ffffff;}
         		 	span.corresp               {background : #ddffdd; }
         		 	span.doi                   {background : #ffffff;}
         		 	span.email                 {font-family : courier; }
         		 	span.etal                  {font-style : italic;}
         		 	span.fpage                 {font-family : courier;}
         		 	span.given-names           {background : #ffffff;}
         		 	span.iso-abbrev            {background : #ffffff;}
         		 	span.issn-epub             {background : #ffffff;}
         		 	span.issn-ppub             {background : #ffffff;}
         		 	span.journal-title         {background : #ffffff;}
         		 	span.lpage                 {font-family : courier;}
         		 	span.mixed-article-title   {font-style : italic ;}
         		 	span.nlm-ta                {background : #ffffff;}
         		 	span.pmc                   {background : #ffffff;}
         		 	span.pmcid                 {background : #ffffff;}
         		 	span.pmid                  {background : #ffffff;}
         		 	span.publisher             {background : #ffffff;}
         		 	span.publisher-id          {background : #ffffff;}
         		 	span.publisher-name        {background : #ffffff;}
         		 	span.source                {background : #ffffff;}
         		 	span.subject               {background : #ffffff;}
         		 	span.surname               {background : #ffffff;}
         		 	span.volume                {font-family : courier; font-weight : bold;}
         		 	span.year                  {font-family : courier ; font-style : italic;}
         			
      </style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"> <span class="nlm-ta" title="nlm-ta">Bioinform Biol Insights</span> <span class="iso-abbrev" title="iso-abbrev">Bioinform Biol Insights</span> <span class="publisher-id" title="publisher-id">BBI</span> <span class="hwp" title="hwp">spbbi</span> <div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"> <span class="journal-title" tagx="journal-title" title="journal-title">Bioinformatics and Biology Insights</span> </div> <span class="issn-epub" tagx="issn" title="issn-epub">1177-9322</span> <div class="publisher" tagx="publisher" title="publisher"> <span class="publisher-name" tagx="publisher-name" title="publisher-name">SAGE Publications</span> <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Sage UK: London, England</span> </div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"> <span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/6669854">6669854</a> </span> <span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1177/1177932219865533">10.1177/1177932219865533</a> </span> <span class="publisher-id" title="publisher-id">10.1177_1177932219865533</span> <div class="article-categories" title="article-categories"> <div class="sub-group" title="subj-group">
: <span class="subject" title="subject">Computational Modeling Protein Structures &amp;amp; Interactions</span>: <span class="subject" title="subject">Original Research</span> </div> </div> <div class="title-group"> <div class="article-title" title="article-title">
Homology Modelling and Molecular Docking Studies of Selected Substituted Benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamide Scaffolds on <i>Plasmodium falciparum</i> Adenylosuccinate Lyase Receptor </div> </div> <div class="contrib-group" title="contrib-group"> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Oduselu</span> <span class="given-names" tagx="given-names" title="given-names">Gbolahan O</span> </span> <a href="#aff1-1177932219865533">1</a> <a href="#aff2-1177932219865533">2</a> </span> <span class="contrib" title="contrib"> <span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-3422-3478</span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ajani</span> <span class="given-names" tagx="given-names" title="given-names">Olayinka O</span> </span> <a href="#aff1-1177932219865533">1</a> <a href="#aff2-1177932219865533">2</a> </span> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ajamma</span> <span class="given-names" tagx="given-names" title="given-names">Yvonne U</span> </span> <a href="#aff1-1177932219865533">1</a> </span> <span class="contrib" title="contrib"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Brors</span> <span class="given-names" tagx="given-names" title="given-names">Benedikt</span> </span> <a href="#aff3-1177932219865533">3</a> </span> <span class="contrib" title="contrib"> <span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-1390-2359</span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Adebiyi</span> <span class="given-names" tagx="given-names" title="given-names">Ezekiel</span> </span> <a href="#aff1-1177932219865533">1</a> <a href="#aff3-1177932219865533">3</a> <a href="#aff4-1177932219865533">4</a> <a href="#corresp1-1177932219865533" /> </span> </div> <span class="citation_author_institution" id="aff1-1177932219865533">[1], </span> <span class="citation_author_institution" id="aff2-1177932219865533">[2], </span> <span class="citation_author_institution" id="aff3-1177932219865533">[3], </span> <span class="citation_author_institution" id="aff4-1177932219865533">[4], </span> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp">
Ezekiel Adebiyi, Covenant University Bioinformatics Research (CUBRe), Covenant University, Km 10 Idiroko Road, P.M.B. 1023, Ota, Ogun State, Nigeria. Email: <span class="email" tagx="email" title="email">ezekiel.adebiyi@covenantuniversity.edu.ng</span> </div> </div> <span class="pub-date-epub" title="pub-date-epub">epub: <span>2019-7-7</span> </span> <span class="pub-date-collection" title="pub-date-collection">collection: <span>2019</span> </span> <span class="volume" tagx="volume" title="volume">13</span> <span class="elocation-id" tagx="elocation-id" title="elocation-id">1177932219865533</span> <span class="history" title="history"> <span class="received" title="received">received: 2019-6-24</span> <span class="accepted" title="accepted">accepted: 2019-6-29</span> </span> <div class="permissions"> <span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses </span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2019</span> </span> <span class="license" title="license"> <span class="license-p" title="license-p">This article is distributed under the terms of the Creative Commons Attribution 4.0 License ( <a href="http://www.creativecommons.org/licenses/by/4.0/">http://www.creativecommons.org/licenses/by/4.0/</a>) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages ( <a href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</a>). </span> </span> </div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p> <i>Plasmodium falciparum</i> adenylosuccinate lyase ( <i>Pf</i>ADSL) is an important enzyme in purine metabolism. Although several benzimidazole derivatives have been commercially developed into drugs, the template design as inhibitor against <i>Pf</i>ADSL has not been fully explored. This study aims to model the 3-dimensional (3D) structure of <i>Pf</i>ADSL, design and predict in silico absorption, distribution, metabolism, excretion and toxicity (ADMET) of 8 substituted benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamide compounds as well as predict the potential interaction modes and binding affinities of the designed ligands with the modelled <i>Pf</i>ADSL. <i>Pf</i>ADSL 3D structure was modelled using SWISS-MODEL, whereas the compounds were designed using ChemDraw Professional. ADMET predictions were done using OSIRIS Property Explorer and Swiss ADME, whereas molecular docking was done with AutoDock Tools. All designed compounds exhibited good in silico ADMET properties, hence can be considered safe for drug development. Binding energies ranged from −6.85 to −8.75 kcal/mol. Thus, they could be further synthesised and developed into active commercial antimalarial drugs. </p> </div> <div class="kwd-group"> <div class="kwd" title="kwd">
ADMET prediction</div> <div class="kwd" title="kwd">
malaria</div> <div class="kwd" title="kwd">
benzimidazole</div> <div class="kwd" title="kwd">
antimalarial activity</div> <div class="kwd" title="kwd">
molecular docking</div> <div class="kwd" title="kwd">
drug target</div> <div class="kwd" title="kwd">
benzimidamide</div> <div class="kwd" title="kwd">
in silico</div> </div> <div class="funding-group" title="funding-group"> <div class="funding" title="funding">
Funding</div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source"> <div class="institution-wrap" title="institution-wrap"> <span class="institution" title="institution">Fogarty National Institutes of Health Common Fund</span> <span class="institution-id" title="institution-id" /> </div> </div> <span class="award-id" tagx="award-id" title="award-id">Grant No: 1U2RTW010679</span> </div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source"> <div class="institution-wrap" title="institution-wrap"> <span class="institution" title="institution">Alexander von Humboldt (AvH) Senior Georg Forster for EA</span> <span class="institution-id" title="institution-id" /> </div> </div> </div> </div> <div class="custom-meta-group" title="custom-meta-group"> <meta name="cover-date" value="January-December 2019" /> </div> </div> </div> <div class="body" title="body"> <div class="intro" title="intro"> <div class="title" tagx="title" title="title">
Introduction</div> <p>Malaria is one of the most challenging infectious diseases to eradicate, especially in Sub-Saharan Africa. <sup> <a href="#bibr1-1177932219865533">1</a> </sup> <i>Plasmodium falciparum</i> remains the most prevalent malaria parasite in the world accounting for 216 million estimated cases in 2016. <sup> <a href="#bibr2-1177932219865533">2</a> </sup> The drug resistance of malaria parasite has led to the need and search for new chemical scaffolds that have novel modes of action and can act through new protein targets. <sup> <a href="#bibr3-1177932219865533">3</a>, <a href="#bibr4-1177932219865533">4</a> </sup> One of such protein targets in <i>P falciparum</i> is the adenylosuccinate lyase (ADSL), which is an important enzyme in purine metabolism. <sup> <a href="#bibr5-1177932219865533">5</a> </sup> The de novo purine biosynthetic pathway that gives rise to the formation of adenosine monophosphate (AMP), catalysed by ADSL, is absent in <i>P falciparum</i>, making it a potential drug target for antimalarial studies. <sup> <a href="#bibr6-1177932219865533">6</a>, <a href="#bibr7-1177932219865533">7</a> </sup> Cassera et al <sup> <a href="#bibr7-1177932219865533">7</a> </sup> reported that 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and its analogues can serve as potential inhibitors for ADSL of <i>P falciparum</i>, hence novel putative antiparasitic agents. Benzimidazole derivatives (substituted benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamides) were considered as potential analogues for AICAR due to similarities in chemical structure ( <a href="#fig1-1177932219865533">Figure 1</a>), and could be evaluated for their antimalarial propensity. Benzimidazole derivatives have been widely used in recent years due to their wide range of pharmacological activities including antimalarial, <sup> <a href="#bibr8-1177932219865533">8</a> </sup> antileishmanial, <sup> <a href="#bibr9-1177932219865533">9</a> </sup> analgesics, <sup> <a href="#bibr10-1177932219865533">10</a> </sup> anticancer, <sup> <a href="#bibr11-1177932219865533">11</a> </sup> antitumour, <sup> <a href="#bibr12-1177932219865533">12</a> </sup> antimicrobial, <sup> <a href="#bibr13-1177932219865533">13</a> </sup> anti-inflammatory, <sup> <a href="#bibr14-1177932219865533">14</a> </sup> antihepatitis C virus, <sup> <a href="#bibr15-1177932219865533">15</a> </sup> antihelmintic, <sup> <a href="#bibr16-1177932219865533">16</a> </sup> antibacterial <sup> <a href="#bibr17-1177932219865533">17</a> </sup> and antitrypanosomal <sup> <a href="#bibr18-1177932219865533">18</a> </sup> activities. Although several benzimidazole derivatives have been synthesised and developed into commercially available drugs, little is known about the design of the template as an inhibitor against <i>P falciparum</i> ADSL ( <i>Pf</i>ADSL). </p> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 1.</span> </a> </div>   <p>Structures of AICAR and benzimidazole showing the regions of similarity.</p> <p>Abbreviation: AICAR, 5-aminoimidazole-4-carboxamide ribonucleotide.</p>   </div> <p>Over the years, different approaches have been used to improve how antimalarial agents are designed, put through clinical trials and eventually released as commercially available drugs. <sup> <a href="#bibr19-1177932219865533">19</a> </sup> One of such approaches is structure-based drug design (SBDD), which relies on the knowledge of the 3-dimensional (3D) structure of the protein target to design a suitable ligand that can function as its potential inhibitor. <sup> <a href="#bibr20-1177932219865533">20</a> </sup> In a situation where the experimental 3D structure of the protein is not available, homology model can be built from its amino acid sequence. <sup> <a href="#bibr21-1177932219865533">21</a> </sup> Molecular docking is an important technique in SBDD, which can be applied in facilitating and speeding up the development of antimalarial agents or drugs that can be active against the deadly malaria parasite. <sup> <a href="#bibr22-1177932219865533">22</a> </sup> Molecular docking has helped scientists to virtually screen a library of ligands (or compounds) against a target protein and predict the binding conformations and affinities of the ligands to the target. <sup> <a href="#bibr19-1177932219865533">19</a> </sup> The aim of this study is to model the 3D structure of <i>Pf</i>ADSL, design and predict the in silico absorption, distribution, metabolism, excretion and toxicity (ADMET) of some substituted benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamide compounds as well as predict the potential interaction modes and binding affinities of the designed ligands with the modelled <i>Pf</i>ADSL. </p> </div> <div class="materials_methods" title="materials|methods"> <div class="title" tagx="title" title="title">
Materials and Methods</div> <div class="homologymodellingofpfadslandthetarget-templatesequencealignment" title="sec"> <div class="title" tagx="title" title="title">
Homology modelling of PfADSL and the target-template sequence alignment</div> <p>The experimental crystal structure of <i>Pf</i>ADSL is not available in the Protein Data Bank (PDB); <sup> <a href="#bibr23-1177932219865533">23</a> </sup> hence, its 3D structure was modelled. The protein ID of the target ( <i>P falciparum</i> adenylosuccinate lyase 3D7 strain) was retrieved from UniProt Knowledgebase (UniProtKB) <sup> <a href="#bibr24-1177932219865533">24</a> </sup> with the accession number Q7KWJ4. Afterwards, the protein ID was submitted to SWISS-MODEL <sup> <a href="#bibr25-1177932219865533">25</a> </sup> web server to develop a model with sufficient query sequence coverage and sequence identity. The most reliable 3D structure was selected based on the Global Model Quality Estimation (GMQE) <sup> <a href="#bibr26-1177932219865533">26</a> </sup> and Qualitative Model Energy Analysis (QMEAN) <sup> <a href="#bibr27-1177932219865533">27</a> </sup> values. The GMQE values are usually between 0 and 1, and the higher the number, the higher the reliability of the predicted structure, while for QMEAN, a value below 4.0 shows reliability. <sup> <a href="#bibr28-1177932219865533">28</a> </sup> The similarity identity between the amino acid sequences of the homology model of <i>Pf</i>ADSL and the template structure used for the homology model were confirmed using Clustal Omega version 1.2.1. <sup> <a href="#bibr29-1177932219865533">29</a> </sup> </p> </div> <div class="structurevalidationofmodelledprotein" title="sec"> <div class="title" tagx="title" title="title">
Structure validation of modelled protein</div> <p>The SWISS-MODEL web server automatically calculates the QMEAN scoring function for the estimation of the local and the global model quality based on the geometry, the interactions and the solvent potential of the protein model. It also provides the z-score ranging from 0 to 1, which are compared with the expected value for any structure. PROCHECK was used to check for the quality of the modelled 3D structure of <i>Pf</i>ADSL generated via SWISS-MODEL. For this structure validation, the .pdb file format of the modelled <i>Pf</i>ADSL was uploaded on the PDBsum web server <sup> <a href="#bibr30-1177932219865533">30</a> </sup> of European Bioinformatics Institute. The .pdb file format of the modelled <i>Pf</i>ADSL was uploaded on the server to obtain both the Ramachandran plot and the Ramachandran plot statistics. While the Ramachandran plot is used in accessing the quality of a modelled protein or an experimental structure, the Ramachandran plot statistics provides information on the total number of amino acid residues found in the favourable, allowed and disallowed regions. <sup> <a href="#bibr31-1177932219865533">31</a> </sup> Also, Verify3D <sup> <a href="#bibr32-1177932219865533">32</a> </sup> was used to validate the structure of the modelled protein, determine how compatible a 3D structure is to its own amino acids and compare the result with that of good-known structures. </p> </div> <div class="alignmentofthepfadslmodelandthetemplatestructure" title="sec"> <div class="title" tagx="title" title="title">
Alignment of the PfADSL model and the template structure</div> <p>The alignment of the <i>Pf</i>ADSL model and template structure was carried out using PyMOL molecular viewer <sup> <a href="#bibr33-1177932219865533">33</a> </sup> to show how closely related the carbon atoms are. This is derived from the root mean square deviation (RMSD) between the positioning of the carbon atoms of both the template and the model that is obtained from the alignment. The lower the RMSD (w.r.t 0), the more closely related the structures are. </p> </div> <div class="ligandmodelling" title="sec"> <div class="title" tagx="title" title="title">
Ligand modelling</div> <p>AICAR analogues are good inhibitors of <i>Pf</i>ADSL <sup> <a href="#bibr7-1177932219865533">7</a> </sup> and similar to benzimidazole, as shown in <a href="#fig1-1177932219865533">Figure 1</a>. Therefore, the benzimidazole derivatives were built as ligands to function as potential inhibitors of <i>Pf</i>ADSL, which is the target protein. The 2-dimensional (2D) structures of the substituted benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamide compounds, <b>4a-h</b> ( <a href="#fig9-1177932219865533">Scheme 1</a>), were built using ChemDraw Professional 15.0 by PerkinElmer USA. Also, ChemDraw was used to generate the simplified molecular-input line-entry system (SMILES) that were converted to their corresponding 3D structures using FRee Online druG 3D conformation generator (FROG) <sup> <a href="#bibr34-1177932219865533">34</a> </sup> and saved in .pdb format. In addition, OpenBabel software <sup> <a href="#bibr35-1177932219865533">35</a> </sup> was used to convert the .pdb files to the AutoDock docking format (.pdbqt), which was further used for the docking simulation. </p> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Scheme 1.</span> </a> </div>   <p>Schematic representation of the compounds <b>4a-h</b>. </p> <p>‘R’ stands for substituents on the compounds; ‘n’ stands for number of CH <sub>2.</sub> </p>   </div> </div> <div class="insilicodrug-likenessandtoxicitypredictions" title="sec"> <div class="title" tagx="title" title="title">
In silico drug-likeness and toxicity predictions</div> <p>Drug-likeness is a prediction that determines whether a particular pharmacological agent has properties consistent with being an orally active drug. <sup> <a href="#bibr36-1177932219865533">36</a> </sup> This prediction is based on an already established concept by Lipinski et al, <sup> <a href="#bibr37-1177932219865533">37</a> </sup> called Lipinski rule of five. The rule predicts that there is likely to be poor absorption or permeation when a compound possesses more than 5H-bond donors, 10H-bond acceptors, molecular weight greater than 500 and the calculated LogP (CLogP) greater than 5. <sup> <a href="#bibr37-1177932219865533">37</a> </sup> The selection of compounds as drug candidates is also determined by a parameter called drug score. <sup> <a href="#bibr38-1177932219865533">38</a> </sup> The higher the drug score value, the higher the chance of the compound being considered as a drug candidate. <sup> <a href="#bibr38-1177932219865533">38</a> </sup> The in silico drug-likeness and toxicity predictions of the designed ligands were carried out using OSIRIS Property Explorer <sup> <a href="#bibr39-1177932219865533">39</a> </sup> and Swiss ADME predictor. <sup> <a href="#bibr40-1177932219865533">40</a>, <a href="#bibr41-1177932219865533">41</a> </sup> OSIRIS Property Explorer programme estimates the mutagenic, tumorigenic, irritant and reproductive risks, and also provides information on the compound’s hydrophilicity (LogP), solubility (LogS), molecular weight, drug-likeness and drug score. <sup> <a href="#bibr42-1177932219865533">42</a> </sup> Meanwhile, SwissADME predictor provides information on the numbers of hydrogen donors, hydrogen acceptors and rotatable bonds, total polar surface area and the synthetic accessibility of the compounds. The ligands were also subjected to Lipinski et al, <sup> <a href="#bibr37-1177932219865533">37</a> </sup> Muegge et al, <sup> <a href="#bibr43-1177932219865533">43</a> </sup> Ghose et al, <sup> <a href="#bibr44-1177932219865533">44</a> </sup> Egan et al <sup> <a href="#bibr45-1177932219865533">45</a> </sup> and Veber et al <sup> <a href="#bibr46-1177932219865533">46</a> </sup> screenings using SwissADME predictor. The analyses of the compounds were compared with that of chloroquine, and only compounds without violation of any of the screenings were used for the molecular docking analysis. </p> </div> <div class="proteinpreparation" title="sec"> <div class="title" tagx="title" title="title">
Protein preparation</div> <p>The homology modelled 3D structure of the target protein, <i>Pf</i>ADSL, was downloaded from SWISS-MODEL in its .pdb format. The modelled protein structure was defined as receptor while the complexed ligands were removed using Chimera software. <sup> <a href="#bibr47-1177932219865533">47</a> </sup> Furthermore, the protein was prepared by the computation of Gasteiger charges, with the addition of polar hydrogens and merging of the nonpolar hydrogens using AutoDockTools 1.5.6. <sup> <a href="#bibr48-1177932219865533">48</a> </sup> </p> </div> <div class="predictionofactivesitesinthemodelledprotein" title="sec"> <div class="title" tagx="title" title="title">
Prediction of active sites in the modelled protein</div> <p>The Computed Atlas of Surface Topography of proteins (CASTp) 3.0 <sup> <a href="#bibr49-1177932219865533">49</a> </sup> was used to predict the active sites that were present in the modelled protein structure. CASTp is an online server that is applied in the identification and measurement of voids on 3D protein structures. <sup> <a href="#bibr50-1177932219865533">50</a> </sup> The modelled 3D protein was submitted on the server, and the necessary amino acids for binding interactions were predicted. <sup> <a href="#bibr50-1177932219865533">50</a> </sup> </p> </div> <div class="moleculardockinganalysis" title="sec"> <div class="title" tagx="title" title="title">
Molecular docking analysis</div> <p>It has been reported that ADSL enzymes, which were used for the docking analyses, are biologically active as homotetramers. <sup> <a href="#bibr51-1177932219865533">51</a>, <a href="#bibr52-1177932219865533">52</a> </sup> The molecular docking studies were carried out using AutoDockTools, which is a free graphic user interface (GUI) for the AutoDock4.2 programme. <sup> <a href="#bibr53-1177932219865533">53</a> </sup> The grid box was constructed using 58, 58, and 40, pointing in x, y, and z directions, respectively, with a grid point spacing of 0.508 Å. The centre grid box is of 14.527 Å, 56.689 Å and −5.122 Å around Arg 17A, Tyr 18A, Asn 312A, His 173C, Asn 90D, Asp 92D, Gln 250D, Arg 338D, Ser 343D and Arg 347D. These amino acids were selected based on the CASTp result and the alignment of the modelled 3D structure to the template structure. In addition, the docking analysis was executed using Lamarckian Genetic Algorithm 4.2, and the macromolecule was kept rigid throughout the docking simulation. The number of genetic algorithm runs was set at 10, and the other docking parameters were left at default values. Ten different conformations were generated for each ligand scored using AutoDock 4.2 scoring functions and were ranked according to their binding energies. AutoDockTools, PyMOL and LigPlot <sup> <a href="#bibr54-1177932219865533">54</a> </sup> were used for the post-docking analyses. </p> </div> </div> <div class="results_discussion" title="results|discussion"> <div class="title" tagx="title" title="title">
Results and Discussion</div> <div class="homologymodellingofpfadslandthetarget-templatesequencealignment" title="sec"> <div class="title" tagx="title" title="title">
Homology modelling of PfADSL and the target-template sequence alignment</div> <p>A 3D structure of <i>Pf</i>ADSL was built using SWISS-MODEL with GMQE of 0.80 and QMEAN of −1.46. Also, <i>Plasmodium vivax</i> ADSL Pv003765 with AMP bound (PDB ID: 2QGA; resolution: 2.01 Å) <sup> <a href="#bibr55-1177932219865533">55</a> </sup> was identified to have the closest template to <i>Pf</i>ADSL with a similarity identity of 63.91% and sequence similarity of 0.50. The GMQE value of 0.80 and QMEAN score of −1.46 indicate that the modelled structure is reliable and has a good quality. <sup> <a href="#bibr26-1177932219865533">26</a>, <a href="#bibr28-1177932219865533">28</a> </sup> </p> <p>The multiple sequence alignment of the amino acid sequences <sup> <a href="#bibr56-1177932219865533">56</a> </sup> of the <i>Pf</i>ADSL (UniProtKB ID: Q7KWJ4) and <i>P vivax</i> ADSL with AMP bound (PDB ID: 2QGA) is shown in <a href="#fig2-1177932219865533">Figure 2</a>. A percentage identity matrix of 63.36% was obtained, which confirms the similarity identity of 63.91% obtained from the homology modelling. </p> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 2.</span> </a> </div>   <p>Alignment of the amino acid sequences of <i>Plasmodium falciparum</i> ADSL and the crystal structure of 2QGA. </p> <p>Abbreviation: ADSL, adenylosuccinate lyase.</p> <p>‘*’ represents positions that have single, fully conserved residue; ‘:’ indicates conservation between groups of strongly similar properties; ‘.’ indicates conservation between groups of weakly similar properties. </p>   </div> </div> <div class="structurevalidationofmodelledprotein" title="sec"> <div class="title" tagx="title" title="title">
Structure validation of modelled protein</div> <p>The plot of the predicted local similarity to target against the residue number of the predicted 3D structure of the modelled protein was graphically represented ( <a href="#fig3-1177932219865533">Figure 3A</a>). The value of most of the residues was close to 1, indicating that the local quality estimate of the residues of the predicted model is good. The residues with values lower than 0.6 were considered to be of low quality. The modelled protein structure also lies within the range of other protein structures in PDB, which confirms its reliability ( <a href="#fig3-1177932219865533">Figure 3B</a>). </p> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 3.</span> </a> </div>   <p>Structure validation of modelled <i>Pf</i>ADSL: (A) Local quality estimate of the residues of the predicted <i>Pf</i>ADSL model; (B) comparison of the predicted <i>Pf</i>ADSL structure with nonredundant set of PDB structures. </p> <p>Abbreviation: <i>Pf</i>ADSL, <i>Plasmodium falciparum</i> adenylosuccinate lyase, PDB, Protein Data Bank. </p>   </div> <p>Both the Ramachandran plot ( <a href="#fig4-1177932219865533">Figure 4A</a>) and the Ramachandran plot statistics ( <a href="#fig4-1177932219865533">Figure 4B</a>) were obtained from PDBsum web server. The Ramachandran plot statistics implied that the modelled 3D structure of <i>Pf</i>ADSL has 91.8% of its residues in the most favoured regions, 7.4% of its residues in additional allowed regions, 0.8% of its residues in the generously allowed regions and 0.0% of its residues in disallowed regions of the Ramachandran plot. This also validates that the modelled 3D structure is a good quality model. Also, the Verify3D plot of the modelled protein ( <a href="#fig4-1177932219865533">Figure 4C</a>) was obtained for the structure validation and it showed as PASS. The 3D environment profile shows that 85.64% of the residues have averaged 3D-1D score ⩾ 0.2, which suggests the validity of the modelled protein. </p> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 4.</span> </a> </div>   <p>Structure validation using (A) Ramachandran plot; (B) Ramachandran plot statistics of the homology modelled <i>Pf</i>ADSL; and (C) Verify3D. </p> <p>Abbreviation: <i>Pf</i>ADSL, <i>Plasmodium falciparum</i> adenylosuccinate lyase. </p>   </div> </div> <div class="alignmentofthepfadslmodelandtemplate(2gqa)structure" title="sec"> <div class="title" tagx="title" title="title">
Alignment of the PfADSL model and template (2GQA) structure</div> <p>A RMSD value of 0.105 Å was obtained from the alignment computed using PyMOL molecular viewer, indicating that the structures were closely related ( <a href="#fig5-1177932219865533">Figure 5</a>). The template structure is represented by the blue helices, whereas the protein model is represented by the green helices. The alignment showed that the chain B and chain C of the dimer template structure (2QGA) corresponded to the chain C and chain D of the tetramer structure of the protein model. Meanwhile, it was observed from the molecular viewer that the binding of the AMP to the amino acid residues of 2QGA at His 168B, Asn 85C, Asp 87C, Gln 245C, Ser 338C, Arg 333C and Arg 342D also corresponded with the binding of the AMP with the amino acid residues of the modelled template at His 173C, Asn 90D, Asp 92D, Gln 250D, Ser 343D, Arg 338D and Arg 347D. </p> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 5.</span> </a> </div>   <p>Alignment of the <i>Pf</i>ADSL model and the 2GQA template structure of <i>Plasmodium vivax</i> ADSL. </p> <p>Abbreviation: <i>Pf</i>ADSL, <i>Plasmodium falciparum</i> adenylosuccinate lyase. </p>   </div> </div> <div class="insilicoresultsofrisksanddrug-likenessofligands" title="sec"> <div class="title" tagx="title" title="title">
In silico results of risks and drug-likeness of ligands</div> <p> <i>a. OSIRIS property explorer result</i>. With the exception of compound <b>4c</b>, all the predicted toxicity risk factors for the 8 designed substituted benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamides were low ( <a href="#table1-1177932219865533">Table 1</a>). Also, the 8 compounds had molecular weights less than 500, which implied that they are likely to be absorbed and are able to reach the place of action when administered as drugs. <sup> <a href="#bibr57-1177932219865533">57</a> </sup> All compounds including the standard drug (chloroquine) had LogP values not higher than 5, suggesting good absorption and permeation across cell membranes. <sup> <a href="#bibr57-1177932219865533">57</a> </sup> Among the compounds, 4-((2-benzyl-1H-benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamide <b>4f</b> had the highest value of drug score (0.83), which is higher than that of chloroquine (0.25). This high value could be as a result of the aliphatic carboxylic acid (phenyl acetic acid) on position 2 of the benzimidazole in <b>4f</b>. In general, the drug score values of compounds <b>4a-h</b> (0.3-0.83) were bigger than that of chloroquine. In addition, it was predicted that all the designed compounds possessed low mutagenic, tumorigenic, irritant and reproductive effective toxicity risks except <b>4c</b>, which was predicted to have a high mutagenic toxicity risk. However, the removal of the amino group on position 5 of the benzoic acid as seen in <b>4h</b> reduced the risk of the mutagenic toxicity of <b>4c</b>. </p> <div class="table-wrap_UNKNOWN"> <span class="label" tagx="label" title="label">Table 1.</span>  <p>Physicochemical properties and toxicity risks of compounds <b>4a-h</b> in comparison with chloroquine as predicted using OSIRIS Property Explorer. </p>  <div class="alternatives" title="alternatives"> <div class="graphic_UNKNOWN" /> <table> <div class="colgroup_UNKNOWN"> <div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div>  <thead> <tr> <th>Compounds</th> <th>Physicochemical properties <hr /> </th> <th>Toxicity risks <hr /> </th> </tr> <tr> <th>Molecular weight</th> <th>cLogP</th> <th>Solubility prediction</th> <th>Drug likeness</th> <th>Drug score</th> <th>Mutagenic</th> <th>Tumorigenic</th> <th>Irritant</th> <th>Reproductive effective</th> </tr> </thead> <tbody> <tr> <td> <b>4a</b> </td> <td>326</td> <td>3.08</td> <td>−3.69</td> <td>4.09</td> <td>0.78</td> <td>Low</td> <td>Low</td> <td>Low</td> <td>Low</td> </tr> <tr> <td> <b>4b</b> </td> <td>360</td> <td>3.69</td> <td>−4.43</td> <td>3.68</td> <td>0.67</td> <td>Low</td> <td>Low</td> <td>Low</td> <td>Low</td> </tr> <tr> <td> <b>4c</b> </td> <td>356</td> <td>1.73</td> <td>−3.85</td> <td>−1.17</td> <td>0.30</td> <td>High</td> <td>Low</td> <td>Low</td> <td>Low</td> </tr> <tr> <td> <b>4d</b> </td> <td>342</td> <td>2.74</td> <td>−3.40</td> <td>3.14</td> <td>0.80</td> <td>Low</td> <td>Low</td> <td>Low</td> <td>Low</td> </tr> <tr> <td> <b>4e</b> </td> <td>341</td> <td>2.40</td> <td>−3.77</td> <td>0.93</td> <td>0.69</td> <td>Low</td> <td>Low</td> <td>Low</td> <td>Low</td> </tr> <tr> <td> <b>4f</b> </td> <td>340</td> <td>3.14</td> <td>−2.54</td> <td>3.63</td> <td>0.83</td> <td>Low</td> <td>Low</td> <td>Low</td> <td>Low</td> </tr> <tr> <td> <b>4g</b> </td> <td>352</td> <td>3.53</td> <td>−2.97</td> <td>2.11</td> <td>0.75</td> <td>Low</td> <td>Low</td> <td>Low</td> <td>Low</td> </tr> <tr> <td> <b>4h</b> </td> <td>341</td> <td>2.40</td> <td>−3.77</td> <td>1.36</td> <td>0.72</td> <td>Low</td> <td>Low</td> <td>Low</td> <td>Low</td> </tr> <tr> <td> <b>Chloroquine</b> </td> <td>319</td> <td>4.01</td> <td>−4.06</td> <td>7.39</td> <td>0.25</td> <td>High</td> <td>Low</td> <td>High</td> <td>Low</td> </tr> </tbody> </table> </div> </div> </div> <div class="b.swissadmeprediction" title="sec"> <div class="title" tagx="title" title="title">
b. SwissADME prediction</div> <p>The numbers of hydrogen bond acceptors (NHA) and hydrogen bond donors (NHD) in compounds <b>4a-h</b> ( <a href="#table2-1177932219865533">Table 2</a>) are in accordance with the rule of five by Lipinski et al. <sup> <a href="#bibr37-1177932219865533">37</a> </sup> The LogS prediction of −5.11 to −3.81 indicated that all the compounds were moderately soluble. Also, the highest value (2.89) of synthetic accessibility was recorded for compound <b>4g</b>, suggesting that it will be the most difficult to synthesise from the compound library. This could be due to the presence of a double bond in position 2 of the benzimidazole. Generally, the synthetic accessibility of all the compounds (2.44-2.89) was within the range of easy synthetic accessibility. It is also interesting to note that none of the compounds violated the Lipinski rule of five, Ghose filter, Veber rule, Egan rule and Muegge rule. This shows that all the ligands can be considered as good lead compounds in drug design. </p> <div class="table-wrap_UNKNOWN"> <span class="label" tagx="label" title="label">Table 2.</span>  <p>ADME prediction of compounds <b>4a-h</b> in comparison with chloroquine, predicted by SwissADME. </p>  <div class="alternatives" title="alternatives"> <div class="graphic_UNKNOWN" /> <table> <div class="colgroup_UNKNOWN"> <div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div>  <thead> <tr> <th>Compounds</th> <th>Formula</th> <th>NHD</th> <th>NHA</th> <th>NRB</th> <th>TPSA <br /><br />(Å <sup>2</sup>) </th> <th>LogP (iLOGP)</th> <th>LogS (ESOL)</th> <th>Synthetic accessibility</th> </tr> </thead> <tbody> <tr> <td> <b>4a</b> </td> <td>C <sub>21</sub>H <sub>18</sub>N <sub>4</sub> </td> <td>2</td> <td>2</td> <td>4</td> <td>67.69</td> <td>2.27</td> <td>−4.53</td> <td>2.44</td> </tr> <tr> <td> <b>4b</b> </td> <td>C <sub>21</sub>H <sub>17</sub>ClN <sub>4</sub> </td> <td>2</td> <td>2</td> <td>4</td> <td>67.69</td> <td>2.11</td> <td>−5.11</td> <td>2.54</td> </tr> <tr> <td> <b>4c</b> </td> <td>C <sub>21</sub>H <sub>20</sub>N <sub>6</sub> </td> <td>4</td> <td>2</td> <td>4</td> <td>119.73</td> <td>1.38</td> <td>−3.81</td> <td>2.74</td> </tr> <tr> <td> <b>4d</b> </td> <td>C <sub>21</sub>H <sub>18</sub>N <sub>4</sub>O </td> <td>3</td> <td>3</td> <td>4</td> <td>87.92</td> <td>2.11</td> <td>−4.38</td> <td>2.52</td> </tr> <tr> <td> <b>4e</b> </td> <td>C <sub>21</sub>H <sub>19</sub>N <sub>5</sub> </td> <td>3</td> <td>2</td> <td>4</td> <td>93.71</td> <td>2.00</td> <td>−4.17</td> <td>2.62</td> </tr> <tr> <td>4f</td> <td>C <sub>22</sub>H <sub>20</sub>N <sub>4</sub> </td> <td>2</td> <td>2</td> <td>5</td> <td>67.69</td> <td>2.11</td> <td>−4.17</td> <td>2.62</td> </tr> <tr> <td> <b>4g</b> </td> <td>C <sub>23</sub>H <sub>20</sub>N <sub>4</sub> </td> <td>2</td> <td>2</td> <td>5</td> <td>67.69</td> <td>2.34</td> <td>−4.98</td> <td>2.89</td> </tr> <tr> <td> <b>4h</b> </td> <td>C <sub>21</sub>H <sub>19</sub>N <sub>5</sub> </td> <td>3</td> <td>2</td> <td>4</td> <td>93.71</td> <td>1.81</td> <td>−4.17</td> <td>2.60</td> </tr> <tr> <td> <b>Chloroquine</b> </td> <td>C <sub>18</sub>H <sub>26</sub>ClN <sub>3</sub> </td> <td>1</td> <td>2</td> <td>8</td> <td>28.16</td> <td>3.95</td> <td>−4.55</td> <td>2.76</td> </tr> </tbody> </table> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Abbreviations: ADME, absorption, distribution, metabolism, excretion; NHA, no. of hydrogen bond acceptors; NHD, no. of hydrogen bond donors; NRB, no. of rotatable bonds; TPSA, total polar surface area. </p> </div> </div> </div> </div> <div class="activesiteidentification" title="sec"> <div class="title" tagx="title" title="title">
Active site identification</div> <p>From the active site prediction, a pocket was identified with an area (SA) of 2919.055 and a volume (SA) of 2797.556 ( <a href="#fig6-1177932219865533">Figure 6</a>). A total of 166 amino acid residues were predicted to be the active sites for the modelled protein. However, the following were chosen as the more favourable sites for the docking analyses due to the similarities observed from the alignment of the modelled structure to the template structure: Arg 17A, Tyr 18A, Asn 312A, His 173C, Asn 90D, Asp 92D, Gln 250D, Arg 338D, Ser 343D, Arg 347D. </p> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 6.</span> </a> </div>   <p>The surface of the binding pocket of the modelled protein as computed using CASTp 3.0. </p>   </div> </div> <div class="moleculardockingresults" title="sec"> <div class="title" tagx="title" title="title">
Molecular docking results</div> <p>The obtained binding energies and hydrogen bonds of compounds <b>4a-h</b> from the molecular docking simulations are detailed in <a href="#table3-1177932219865533">Table 3</a>, whereas the docked conformation of AICAR and ( <i>E</i>)-4-((2-styryl-1H-benzo[d]imidazol-1-yl)methyl)benzimidamide ( <b>4g</b>) in the active sites of <i>Pf</i>ADSL is presented in <a href="#fig7-1177932219865533">Figures 7</a> and <a href="#fig8-1177932219865533">8</a>, respectively. Structure–activity relationship studies based on the observed dock score values of the compounds suggest that the presence of amidine group, RC(=NH)-NH <sub>2</sub>, on the compounds could be responsible for the low binding energies and strong binding affinity ( <a href="#table3-1177932219865533">Table 3</a>). Also, the presence of amino group on position 2 of the substituted phenyl in <b>4e</b> (–7.48 kcal/mol) increased the binding affinity of the compound as against it being on position 3 as observed in <b>4h</b> (–7.20 kcal/mol). The di-substitution of amino groups on positions 3 and 5 of the substituted phenyl in <b>4e</b> did not have a positive impact on the binding energy but rather reduced its binding affinity (–6.85 kcal/mol) as against the mono-substitutions on position 2 of <b>4e</b> and position 3 on <b>4h</b>. </p> <div class="table-wrap_UNKNOWN"> <span class="label" tagx="label" title="label">Table 3.</span>  <p>Energy-based interactions and hydrogen bonds for benzimidazole derivatives <b>4a-h</b>, AICAR and AMP docked into modelled <i>Pf</i>ADSL. </p>  <div class="alternatives" title="alternatives"> <div class="graphic_UNKNOWN" /> <table> <div class="colgroup_UNKNOWN"> <div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div> <div class="colgroup_UNKNOWN"><div class="col_UNKNOWN" /></div>  <thead> <tr> <th>Compounds</th> <th>Binding energies (Kcal/mol)</th> <th>Hydrogen bonds and the bond lengths</th> </tr> </thead> <tbody> <tr> <td> <b>4a</b> </td> <td>−7.52</td> <td>Ser 298A (3.01 Å), Ser 299A (3.19 Å)</td> </tr> <tr> <td> <b>4b</b> </td> <td>−7.85</td> <td>Ser 298A (3.17 Å), Ser 299A (2.98 Å)</td> </tr> <tr> <td> <b>4c</b> </td> <td>−6.85</td> <td>Asn 90D (2.90 Å), Thr 124D (2.90 Å), Thr 300A (2.67 Å)</td> </tr> <tr> <td> <b>4d</b> </td> <td>−7.03</td> <td>Ser 298A (2.87 Å), Ser 299A (3.10 Å), Thr 124D (2.79 Å)</td> </tr> <tr> <td> <b>4e</b> </td> <td>−7.48</td> <td>Gln 250D (3.05 Å), Ile 296A (2.71 Å)</td> </tr> <tr> <td> <b>4f</b> </td> <td>−8.09</td> <td>Glu 295A (2.46 Å), Asn 306A (2.70 Å)</td> </tr> <tr> <td> <b>4g</b> </td> <td>−8.75</td> <td>Ser 299A (3.02 Å), Thr 124D (2.97 Å)</td> </tr> <tr> <td> <b>4h</b> </td> <td>−7.20</td> <td>Ser 298A (3.17 Å), Ser 299A (3.25 Å), Asp 92D (2.77 Å)</td> </tr> <tr> <td>AICAR</td> <td>−5.49</td> <td>Ser 298A (2.92 Å), Ser 299A (2.81 Å), His 91D (3.04 Å), Thr 172 C (2.76 Å), Lys 304A (2.96 Å), His 173C (2.90 Å) </td> </tr> <tr> <td>AMP</td> <td>−5.10</td> <td>Tyr 18A (2.56 Å), Asn 312A (3.04 Å), Arg 17A (2.94 Å), Asn 90D (2.72 Å), Gln 250D (2.72 Å), Arg 338D (3.01 Å), Ser 343D (2.95 Å), Arg 347 (2.76 Å) </td> </tr> </tbody> </table> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>Abbreviations: AICAR, 5-aminoimidazole-4-carboxamide ribonucleotide; AMP, adenosine monophosphate. </p> </div> </div> </div> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 7.</span> </a> </div>   <p>Molecular docking interactions between AICAR and the binding sites of <i>Pf</i>ADSL: (A) 2D model of the interactions between AICAR and <i>Pf</i>ADSL; (B) 3D model of the interactions between AICAR and the binding sites of <i>Pf</i>ADSL. </p> <p>Abbreviation: AICAR, 5-aminoimidazole-4-carboxamide ribonucleotide; <i>Pf</i>ADSL, <i>Plasmodium falciparum</i> adenylosuccinate lyase. </p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"> <a href="http://doi.org/"> <span class="label" tagx="label" title="label">Figure 8.</span> </a> </div>   <p>Molecular docking interactions between <b>4g</b> and the binding sites of <i>Pf</i>ADSL: (A) 2D model of the interactions; (B) 3D model of the interactions. </p> <p>Abbreviation: <i>Pf</i>ADSL, <i>Plasmodium falciparum</i> adenylosuccinate lyase. </p>   </div> <p>Furthermore, all the designed compounds exhibited dock score values between −6.85 and −8.75 kcal/mol, having lower binding energies than that of the complexed ligand (AMP) that had a binding energy of −5.10 kcal/mol. Also, the binding energies of the compounds were lower than AICAR (–5.49 kcal/mol), which has been reported to be a potential inhibitor of <i>Pf</i>ADSL. <sup> <a href="#bibr7-1177932219865533">7</a> </sup> The lowest autodock score and the best interactions were used to ascertain the compound with the best conformation. <sup> <a href="#bibr2-1177932219865533">2</a> </sup> The best dock score among the designed benzimidazole derivatives was −8.75 kcal/mol for compound <b>4g</b>. The hydrogen bond formed between compound <b>4g</b> and the amino acid residues (Ser 299A, Thr 124D) of <i>Pf</i>ADSL also validates the functional and structural stability of the ligand-protein complex. <sup> <a href="#bibr2-1177932219865533">2</a> </sup> Thus, the binding model reported in this study suggests that these substituted benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamides behave as <i>Pf</i>ADSL inhibitors and show some key structural points to be considered in future optimization. </p> </div> </div> <div class="conclusions" title="conclusions"> <div class="title" tagx="title" title="title">
Conclusion</div> <p> <i>Pf</i>ADSL is a potential drug target that can be considered in the design of antimalarial compounds to combat the malaria menace. This study gives an insight into the design and prediction of potential interaction modes and binding affinities of 8 substituted benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamide compounds with homology modelled <i>Pf</i>ADSL. ( <i>E</i>)-4-((2-styryl-1H-benzo[ <i>d</i>]imidazol-1-yl)methyl)benzimidamide, <b>4g</b>, had the highest dock score value among the designed ligands. All the designed compounds possessed good in silico ADMET properties, demonstrating their safety for further synthesis and development into active commercially available antimalarial drugs. Also, experimental characterization is needed for further validation of the protein target. </p> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <p>The authors acknowledge Covenant University for the infrastructural support of this work and also thank Jide Ayodele of Covenant University Bioinformatics Research (CUBRe) for assisting with logistics. </p> </div> <div class="fn-group" title="fn-group"> <div class="fn-type-financial-disclosure" title="financial-disclosure"> <p> <b>Funding:</b>The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Fogarty National Institutes of Health Common Fund (Grant No: 1U2RTW010679) and Alexander von Humboldt (AvH) Senior Georg Forster for EA. </p> </div> <div class="fn-type-COI-statement" title="COI-statement"> <p> <b>Declaration of conflicting interests:</b>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. </p> </div> <div class="fn-type-con" title="con"> <p> <b>Author Contributions:</b> BB and EA determined the choice of the protein target. EA, OOA, and GOO put up the general concepts and design of the study. GOO carried out the implementation of these concepts. GOO, OOA, YUA and EA carried out the analysis of the work. GOO wrote the paper. GOO, OOA, YUA and EA revised the manuscript. </p> </div> <div class="fn-type-other" title="other"> <p> <b>ORCID iDs:</b> Olayinka O Ajani <span class="inline-graphic" title="inline-graphic" /> <a href="https://orcid.org/0000-0002-3422-3478">https://orcid.org/0000-0002-3422-3478</a> </p> <p>Ezekiel Adebiyi <span class="inline-graphic" title="inline-graphic" /> <a href="https://orcid.org/0000-0002-1390-2359">https://orcid.org/0000-0002-1390-2359</a> </p> </div> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"> <a name="bibr1-1177932219865533" /> <span class="label" tagx="label" title="label">1</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Durojaye</span> <span class="given-names" tagx="given-names" title="given-names">OA</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ilo</span> <span class="given-names" tagx="given-names" title="given-names">CC</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Okeowhor</span> <span class="given-names" tagx="given-names" title="given-names">D</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">The malaria concept in pregnancy and the mechanism of evading the immune system by the malaria parasite </span>. <span class="source" tagx="source" title="source">South Asian J Parasitol</span>. <span class="year" tagx="year" title="year">2019</span>; <span class="volume" tagx="volume" title="volume">2</span>: <span class="fpage" tagx="fpage" title="fpage">1</span>– <span class="lpage" tagx="lpage" title="lpage">7</span>. </span> </li> <li tag="ref"> <a name="bibr2-1177932219865533" /> <span class="label" tagx="label" title="label">2</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Singh</span> <span class="given-names" tagx="given-names" title="given-names">IV</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Mishra</span> <span class="given-names" tagx="given-names" title="given-names">S.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Molecular docking studies of benzamide derivatives for PfDHODH inhibitor as potent antimalarial agent </span>. <span class="source" tagx="source" title="source">Am J Biochem Molec Biol</span>. <span class="year" tagx="year" title="year">2019</span>; <span class="volume" tagx="volume" title="volume">9</span>: <span class="fpage" tagx="fpage" title="fpage">1</span>– <span class="lpage" tagx="lpage" title="lpage">6</span>. </span> </li> <li tag="ref"> <a name="bibr3-1177932219865533" /> <span class="label" tagx="label" title="label">3</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Reynolds</span> <span class="given-names" tagx="given-names" title="given-names">JJ.</span> </span> </span> <span class="source" tagx="source" title="source">Structure-Based Drug Discovery Against a Novel Antimalarial Drug Target, S-Adenosylmethionine Decarboxylase/Ornithine Decarboxylase </span> [Doctoral dissertation]. <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Pretoria, South Africa</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">University of Pretoria</span>; <span class="year" tagx="year" title="year">2013</span>. </span> </li> <li tag="ref"> <a name="bibr4-1177932219865533" /> <span class="label" tagx="label" title="label">4</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Pasupureddy</span> <span class="given-names" tagx="given-names" title="given-names">R</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Seshadri</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Pande</span> <span class="given-names" tagx="given-names" title="given-names">V</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Dixit</span> <span class="given-names" tagx="given-names" title="given-names">R</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Pandey</span> <span class="given-names" tagx="given-names" title="given-names">KC.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Current scenario and future strategies to fight artemisinin resistance</span>. <span class="source" tagx="source" title="source">Parasitol Res</span>. <span class="year" tagx="year" title="year">2019</span>; <span class="volume" tagx="volume" title="volume">118</span>: <span class="fpage" tagx="fpage" title="fpage">29</span>– <span class="lpage" tagx="lpage" title="lpage">42</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/30478733">30478733</a> </span> </span> </li> <li tag="ref"> <a name="bibr5-1177932219865533" /> <span class="label" tagx="label" title="label">5</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Jurecka</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zikanova</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kmoch</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Tylki-Szymańska</span> <span class="given-names" tagx="given-names" title="given-names">A.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Adenylosuccinate lyase deficiency</span>. <span class="source" tagx="source" title="source">J Inherit Metabol Dis</span>. <span class="year" tagx="year" title="year">2015</span>; <span class="volume" tagx="volume" title="volume">38</span>: <span class="fpage" tagx="fpage" title="fpage">231</span>– <span class="lpage" tagx="lpage" title="lpage">242</span>. </span> </li> <li tag="ref"> <a name="bibr6-1177932219865533" /> <span class="label" tagx="label" title="label">6</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bulusu</span> <span class="given-names" tagx="given-names" title="given-names">V</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Srinivasan</span> <span class="given-names" tagx="given-names" title="given-names">B</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bopanna</span> <span class="given-names" tagx="given-names" title="given-names">MP</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Balaram</span> <span class="given-names" tagx="given-names" title="given-names">H.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Elucidation of the substrate specificity, kinetic and catalytic mechanism of adenylosuccinate lyase from Plasmodium falciparum </span>. <span class="source" tagx="source" title="source">Biochim Biophys Acta</span>. <span class="year" tagx="year" title="year">2009</span>; <span class="volume" tagx="volume" title="volume">1794</span>: <span class="fpage" tagx="fpage" title="fpage">642</span>– <span class="lpage" tagx="lpage" title="lpage">654</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/19111634">19111634</a> </span> </span> </li> <li tag="ref"> <a name="bibr7-1177932219865533" /> <span class="label" tagx="label" title="label">7</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Cassera</span> <span class="given-names" tagx="given-names" title="given-names">MB</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zhang</span> <span class="given-names" tagx="given-names" title="given-names">Y</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Hazleton</span> <span class="given-names" tagx="given-names" title="given-names">KZ</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Schramm</span> <span class="given-names" tagx="given-names" title="given-names">VL.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Purine and pyrimidine pathways as targets in Plasmodium falciparum</span>. <span class="source" tagx="source" title="source">Curr Top Med Chem</span>. <span class="year" tagx="year" title="year">2011</span>; <span class="volume" tagx="volume" title="volume">11</span>: <span class="fpage" tagx="fpage" title="fpage">2103</span>– <span class="lpage" tagx="lpage" title="lpage">2115</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/21619511">21619511</a> </span> </span> </li> <li tag="ref"> <a name="bibr8-1177932219865533" /> <span class="label" tagx="label" title="label">8</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sharma</span> <span class="given-names" tagx="given-names" title="given-names">K</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Shrivastava</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Mehra</span> <span class="given-names" tagx="given-names" title="given-names">RN</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Synthesis of novel benzimidazole acrylonitriles for inhibition of Plasmodium falciparum growth by dual target inhibition </span>. <span class="source" tagx="source" title="source">Arch Pharm (Weinheim)</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">351</span>: <span class="fpage" tagx="fpage" title="fpage">1700251</span>. </span> </li> <li tag="ref"> <a name="bibr9-1177932219865533" /> <span class="label" tagx="label" title="label">9</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Tonelli</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Gabriele</span> <span class="given-names" tagx="given-names" title="given-names">E</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Piazza</span> <span class="given-names" tagx="given-names" title="given-names">F</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Benzimidazole derivatives endowed with potent antileishmanial activity</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">33</span>: <span class="fpage" tagx="fpage" title="fpage">210</span>– <span class="lpage" tagx="lpage" title="lpage">226</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29233048">29233048</a> </span> </span> </li> <li tag="ref"> <a name="bibr10-1177932219865533" /> <span class="label" tagx="label" title="label">10</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Cheretaev</span> <span class="given-names" tagx="given-names" title="given-names">IV</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Korenyuk</span> <span class="given-names" tagx="given-names" title="given-names">II</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Nozdrachev</span> <span class="given-names" tagx="given-names" title="given-names">AD.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Neurotropic, psychoactive, and analgesic properties of benzimidazole and its derivatives: physiological mechanisms </span>. <span class="source" tagx="source" title="source">Neurosci Behav Physiol</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">48</span>: <span class="fpage" tagx="fpage" title="fpage">848</span>– <span class="lpage" tagx="lpage" title="lpage">853</span>. </span> </li> <li tag="ref"> <a name="bibr11-1177932219865533" /> <span class="label" tagx="label" title="label">11</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Cheong</span> <span class="given-names" tagx="given-names" title="given-names">JE</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zaffagni</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Chung</span> <span class="given-names" tagx="given-names" title="given-names">I</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Synthesis and anticancer activity of novel water soluble benzimidazole carbamates</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">144</span>: <span class="fpage" tagx="fpage" title="fpage">372</span>– <span class="lpage" tagx="lpage" title="lpage">385</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29288939">29288939</a> </span> </span> </li> <li tag="ref"> <a name="bibr12-1177932219865533" /> <span class="label" tagx="label" title="label">12</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Rashid</span> <span class="given-names" tagx="given-names" title="given-names">N</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kiran</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ashraf</span> <span class="given-names" tagx="given-names" title="given-names">Z</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Synthesis, characterization, antitumor, antibacterial and urease inhibitory activity of a small series of N-tosyl benzimidazoles </span>. <span class="source" tagx="source" title="source">J Chem Soc Pakistan</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">40</span>: <span class="fpage" tagx="fpage" title="fpage">366</span>– <span class="lpage" tagx="lpage" title="lpage">375</span>. </span> </li> <li tag="ref"> <a name="bibr13-1177932219865533" /> <span class="label" tagx="label" title="label">13</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Manju</span> <span class="given-names" tagx="given-names" title="given-names">PT</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Smith</span> <span class="given-names" tagx="given-names" title="given-names">AA</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Padmaja</span> <span class="given-names" tagx="given-names" title="given-names">V</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">In silico design, synthesis and in vitro anti-tubercular and anti-microbial screening of novel benzimidazole derivatives </span>. <span class="source" tagx="source" title="source">Int J Pharmaceut Sci Res</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">9</span>: <span class="fpage" tagx="fpage" title="fpage">3705</span>– <span class="lpage" tagx="lpage" title="lpage">3711</span>. </span> </li> <li tag="ref"> <a name="bibr14-1177932219865533" /> <span class="label" tagx="label" title="label">14</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kumar</span> <span class="given-names" tagx="given-names" title="given-names">PL</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bharathi</span> <span class="given-names" tagx="given-names" title="given-names">T</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Aravind</span> <span class="given-names" tagx="given-names" title="given-names">K</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Synthesis and anti-inflammatory activity of N-(2-(1H-indol-2yl)-1H-benzoimidazol-1-yl)benzamide</span>. <span class="source" tagx="source" title="source">World J Pharm Pharmaceut Sci</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">7</span>: <span class="fpage" tagx="fpage" title="fpage">776</span>– <span class="lpage" tagx="lpage" title="lpage">783</span>. </span> </li> <li tag="ref"> <a name="bibr15-1177932219865533" /> <span class="label" tagx="label" title="label">15</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Patil</span> <span class="given-names" tagx="given-names" title="given-names">VM</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Gupta</span> <span class="given-names" tagx="given-names" title="given-names">SP.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Structural flexibility in HCV NS5B polymerase and molecular modelling of anti-HCV drugs </span>. <span class="source" tagx="source" title="source">Curr Chem Biol</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">12</span>: <span class="fpage" tagx="fpage" title="fpage">65</span>– <span class="lpage" tagx="lpage" title="lpage">87</span>. </span> </li> <li tag="ref"> <a name="bibr16-1177932219865533" /> <span class="label" tagx="label" title="label">16</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Majewsky</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Castel</span> <span class="given-names" tagx="given-names" title="given-names">D</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Le Dret</span> <span class="given-names" tagx="given-names" title="given-names">L</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Systematic identification of suspected anthelmintic benzimidazole metabolites using LC–MS/MS </span>. <span class="source" tagx="source" title="source">J Pharm Biomed Anal</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">151</span>: <span class="fpage" tagx="fpage" title="fpage">151</span>– <span class="lpage" tagx="lpage" title="lpage">158</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29328982">29328982</a> </span> </span> </li> <li tag="ref"> <a name="bibr17-1177932219865533" /> <span class="label" tagx="label" title="label">17</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bistrovic</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Krstulovic</span> <span class="given-names" tagx="given-names" title="given-names">L</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Stolic</span> <span class="given-names" tagx="given-names" title="given-names">I</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Synthesis, anti-bacterial and anti-protozoal activities of amidinobenzimidazole derivatives and their interactions with DNA and RNA </span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">33</span>: <span class="fpage" tagx="fpage" title="fpage">1323</span>– <span class="lpage" tagx="lpage" title="lpage">1334</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/30165753">30165753</a> </span> </span> </li> <li tag="ref"> <a name="bibr18-1177932219865533" /> <span class="label" tagx="label" title="label">18</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Pomel</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Dubar</span> <span class="given-names" tagx="given-names" title="given-names">F</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Forge</span> <span class="given-names" tagx="given-names" title="given-names">D</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Loiseau</span> <span class="given-names" tagx="given-names" title="given-names">PM</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Biot</span> <span class="given-names" tagx="given-names" title="given-names">C.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">New heterocyclic compounds: synthesis and antitrypanosomal properties</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem</span>. <span class="year" tagx="year" title="year">2015</span>; <span class="volume" tagx="volume" title="volume">23</span>: <span class="fpage" tagx="fpage" title="fpage">5168</span>– <span class="lpage" tagx="lpage" title="lpage">5174</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/25835356">25835356</a> </span> </span> </li> <li tag="ref"> <a name="bibr19-1177932219865533" /> <span class="label" tagx="label" title="label">19</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Singh</span> <span class="given-names" tagx="given-names" title="given-names">P</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kumari</span> <span class="given-names" tagx="given-names" title="given-names">K</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Awasthi</span> <span class="given-names" tagx="given-names" title="given-names">SK</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Chandra</span> <span class="given-names" tagx="given-names" title="given-names">R.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Virtual screening and docking studies of synthesised chalcones: potent anti-malarial drug </span>. <span class="source" tagx="source" title="source">Int J Drug Dev Res</span>. <span class="year" tagx="year" title="year">2016</span>; <span class="volume" tagx="volume" title="volume">8</span>: <span class="fpage" tagx="fpage" title="fpage">49</span>– <span class="lpage" tagx="lpage" title="lpage">56</span>. </span> </li> <li tag="ref"> <a name="bibr20-1177932219865533" /> <span class="label" tagx="label" title="label">20</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Barcellos</span> <span class="given-names" tagx="given-names" title="given-names">MP</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Santos</span> <span class="given-names" tagx="given-names" title="given-names">CB</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Federico</span> <span class="given-names" tagx="given-names" title="given-names">LB</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Almeida</span> <span class="given-names" tagx="given-names" title="given-names">PF</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">da Silva</span> <span class="given-names" tagx="given-names" title="given-names">CHTP</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Taft</span> <span class="given-names" tagx="given-names" title="given-names">CA.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Pharmacophore and structure-based drug design, molecular dynamics and admet/tox studies to design novel potential pad4 inhibitors </span>. <span class="source" tagx="source" title="source">J Biomol Struct Dyn</span>. <span class="year" tagx="year" title="year">2019</span>; <span class="volume" tagx="volume" title="volume">37</span>: <span class="fpage" tagx="fpage" title="fpage">966</span>– <span class="lpage" tagx="lpage" title="lpage">981</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29493425">29493425</a> </span> </span> </li> <li tag="ref"> <a name="bibr21-1177932219865533" /> <span class="label" tagx="label" title="label">21</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Muhammed</span> <span class="given-names" tagx="given-names" title="given-names">MT</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Aki-Yalcin</span> <span class="given-names" tagx="given-names" title="given-names">E.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Homology modeling in drug discovery: overview, current applications, and future perspectives</span>. <span class="source" tagx="source" title="source">Chem Biol Drug Des</span>. <span class="year" tagx="year" title="year">2019</span>; <span class="volume" tagx="volume" title="volume">93</span>: <span class="fpage" tagx="fpage" title="fpage">12</span>– <span class="lpage" tagx="lpage" title="lpage">20</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/30187647">30187647</a> </span> </span> </li> <li tag="ref"> <a name="bibr22-1177932219865533" /> <span class="label" tagx="label" title="label">22</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ugwu</span> <span class="given-names" tagx="given-names" title="given-names">DI</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Okoro</span> <span class="given-names" tagx="given-names" title="given-names">UC</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ukoha</span> <span class="given-names" tagx="given-names" title="given-names">PO</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Okafor</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ibezim</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kumar</span> <span class="given-names" tagx="given-names" title="given-names">NM.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Synthesis, characterisation, molecular docking and in vitro antimalarial properties of new carboxamides bearing sulphonamide </span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span>. <span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">135</span>: <span class="fpage" tagx="fpage" title="fpage">349</span>– <span class="lpage" tagx="lpage" title="lpage">369</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/28460310">28460310</a> </span> </span> </li> <li tag="ref"> <a name="bibr23-1177932219865533" /> <span class="label" tagx="label" title="label">23</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Burley</span> <span class="given-names" tagx="given-names" title="given-names">SK</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Berman</span> <span class="given-names" tagx="given-names" title="given-names">HM</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bhikadiya</span> <span class="given-names" tagx="given-names" title="given-names">C</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy </span>. <span class="source" tagx="source" title="source">Nucleic Acids Res</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">47</span>: <span class="fpage" tagx="fpage" title="fpage">D464</span>– <span class="lpage" tagx="lpage" title="lpage">D474</span>. </span> </li> <li tag="ref"> <a name="bibr24-1177932219865533" /> <span class="label" tagx="label" title="label">24</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="collab'">collab: UniProt Consortium</span>. <span class="mixed-article-title" title="mixed-article-title">UniProt: a worldwide hub of protein knowledge</span>. <span class="source" tagx="source" title="source">Nucleic Acids Res</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">47</span>: <span class="fpage" tagx="fpage" title="fpage">D506</span>– <span class="lpage" tagx="lpage" title="lpage">D515</span>. </span> </li> <li tag="ref"> <a name="bibr25-1177932219865533" /> <span class="label" tagx="label" title="label">25</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Waterhouse</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bertoni</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bienert</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">SWISS-MODEL: homology modelling of protein structures and complexes</span>. <span class="source" tagx="source" title="source">Nucleic Acids Res</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">46</span>: <span class="fpage" tagx="fpage" title="fpage">W296</span>– <span class="lpage" tagx="lpage" title="lpage">W303</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29788355">29788355</a> </span> </span> </li> <li tag="ref"> <a name="bibr26-1177932219865533" /> <span class="label" tagx="label" title="label">26</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Cardoso</span> <span class="given-names" tagx="given-names" title="given-names">JM</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Fonseca</span> <span class="given-names" tagx="given-names" title="given-names">L</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Egas</span> <span class="given-names" tagx="given-names" title="given-names">C</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Abrantes</span> <span class="given-names" tagx="given-names" title="given-names">I.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Cysteine proteases secreted by the pinewood nematode, Bursaphelenchus xylophilus: in silico analysis </span>. <span class="source" tagx="source" title="source">Comput Biol Chem</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">77</span>: <span class="fpage" tagx="fpage" title="fpage">291</span>– <span class="lpage" tagx="lpage" title="lpage">296</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/30399505">30399505</a> </span> </span> </li> <li tag="ref"> <a name="bibr27-1177932219865533" /> <span class="label" tagx="label" title="label">27</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Benkert</span> <span class="given-names" tagx="given-names" title="given-names">P</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kunzli</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Schwede</span> <span class="given-names" tagx="given-names" title="given-names">T.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">QMEAN server for protein model quality estimation</span>. <span class="source" tagx="source" title="source">Nucleic Acids Res</span>. <span class="year" tagx="year" title="year">2009</span>; <span class="volume" tagx="volume" title="volume">37</span>: <span class="fpage" tagx="fpage" title="fpage">W510</span>– <span class="lpage" tagx="lpage" title="lpage">W514</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/19429685">19429685</a> </span> </span> </li> <li tag="ref"> <a name="bibr28-1177932219865533" /> <span class="label" tagx="label" title="label">28</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Patel</span> <span class="given-names" tagx="given-names" title="given-names">B</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Singh</span> <span class="given-names" tagx="given-names" title="given-names">V</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Patel</span> <span class="given-names" tagx="given-names" title="given-names">D</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Structural Bioinformatics</span>. In: <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Shaik</span> <span class="given-names" tagx="given-names" title="given-names">NA</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Hakeem</span> <span class="given-names" tagx="given-names" title="given-names">KR</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Banganapalli</span> <span class="given-names" tagx="given-names" title="given-names">B</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span>, eds. <span class="source" tagx="source" title="source">Essentials of Bioinformatics</span>, <span class="volume" tagx="volume" title="volume">vol. I</span> <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Cham, Switzerland</span>: <span class="publisher-name" tagx="publisher-name" title="publisher-name">Springer</span>; <span class="volume" tagx="volume" title="volume">2019</span>: <span class="fpage" tagx="fpage" title="fpage">169</span>– <span class="lpage" tagx="lpage" title="lpage">199</span>. </span> </li> <li tag="ref"> <a name="bibr29-1177932219865533" /> <span class="label" tagx="label" title="label">29</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sainy</span> <span class="given-names" tagx="given-names" title="given-names">J</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Sharma</span> <span class="given-names" tagx="given-names" title="given-names">R.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Synthesis, antimalarial evaluation and molecular docking studies of some thiolactone derivatives </span>. <span class="source" tagx="source" title="source">J Molec Struct</span>. <span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">1134</span>: <span class="fpage" tagx="fpage" title="fpage">350</span>– <span class="lpage" tagx="lpage" title="lpage">359</span>. </span> </li> <li tag="ref"> <a name="bibr30-1177932219865533" /> <span class="label" tagx="label" title="label">30</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Laskowski</span> <span class="given-names" tagx="given-names" title="given-names">RA.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">PDBsum new things</span>. <span class="source" tagx="source" title="source">Nucleic Acids Res</span>. <span class="year" tagx="year" title="year">2008</span>; <span class="volume" tagx="volume" title="volume">37</span>: <span class="fpage" tagx="fpage" title="fpage">D355</span>– <span class="lpage" tagx="lpage" title="lpage">D359</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/18996896">18996896</a> </span> </span> </li> <li tag="ref"> <a name="bibr31-1177932219865533" /> <span class="label" tagx="label" title="label">31</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Laskowski</span> <span class="given-names" tagx="given-names" title="given-names">RA</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">MacArthur</span> <span class="given-names" tagx="given-names" title="given-names">MW</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Moss</span> <span class="given-names" tagx="given-names" title="given-names">DS</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Thornton</span> <span class="given-names" tagx="given-names" title="given-names">JM.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">PROCHECK: a program to check the stereochemical quality of protein structures</span>. <span class="source" tagx="source" title="source">J Appl Crystal</span>. <span class="year" tagx="year" title="year">1993</span>; <span class="volume" tagx="volume" title="volume">26</span>: <span class="fpage" tagx="fpage" title="fpage">283</span>– <span class="lpage" tagx="lpage" title="lpage">291</span>. </span> </li> <li tag="ref"> <a name="bibr32-1177932219865533" /> <span class="label" tagx="label" title="label">32</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Eisenberg</span> <span class="given-names" tagx="given-names" title="given-names">D</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lüthy</span> <span class="given-names" tagx="given-names" title="given-names">R</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Bowie</span> <span class="given-names" tagx="given-names" title="given-names">JU.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">[20] VERIFY3D: assessment of protein models with three-dimensional profiles</span>. <span class="source" tagx="source" title="source">Methods Enzymol</span> <span class="year" tagx="year" title="year">1997</span>; <span class="volume" tagx="volume" title="volume">277</span>: <span class="fpage" tagx="fpage" title="fpage">396</span>– <span class="lpage" tagx="lpage" title="lpage">404</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/9379925">9379925</a> </span> </span> </li> <li tag="ref"> <a name="bibr33-1177932219865533" /> <span class="label" tagx="label" title="label">33</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">De Lano</span> <span class="given-names" tagx="given-names" title="given-names">WL</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Pymol: an open-source molecular graphics tool</span>. <span class="source" tagx="source" title="source">CCP4 Newslett Protein Crystal</span>. <span class="year" tagx="year" title="year">2002</span>; <span class="volume" tagx="volume" title="volume">40</span>: <span class="fpage" tagx="fpage" title="fpage">82</span>– <span class="lpage" tagx="lpage" title="lpage">92</span>. </span> </li> <li tag="ref"> <a name="bibr34-1177932219865533" /> <span class="label" tagx="label" title="label">34</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Leite</span> <span class="given-names" tagx="given-names" title="given-names">TB</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Gomes</span> <span class="given-names" tagx="given-names" title="given-names">D</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Miteva</span> <span class="given-names" tagx="given-names" title="given-names">MA</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Chomilier</span> <span class="given-names" tagx="given-names" title="given-names">J</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Villoutreix</span> <span class="given-names" tagx="given-names" title="given-names">BO</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Tuffery</span> <span class="given-names" tagx="given-names" title="given-names">P.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">FROG: a FRee Online druG 3D conformation generator</span>. <span class="source" tagx="source" title="source">Nucleic Acids Res</span>. <span class="year" tagx="year" title="year">2007</span>; <span class="volume" tagx="volume" title="volume">35</span>: <span class="fpage" tagx="fpage" title="fpage">W568</span>– <span class="lpage" tagx="lpage" title="lpage">W572</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/17485475">17485475</a> </span> </span> </li> <li tag="ref"> <a name="bibr35-1177932219865533" /> <span class="label" tagx="label" title="label">35</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">O’Boyle</span> <span class="given-names" tagx="given-names" title="given-names">NM</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Banck</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">James</span> <span class="given-names" tagx="given-names" title="given-names">CA</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Morley</span> <span class="given-names" tagx="given-names" title="given-names">C</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Vandermeersch</span> <span class="given-names" tagx="given-names" title="given-names">T</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Hutchison</span> <span class="given-names" tagx="given-names" title="given-names">GR.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Open Babel: an open chemical toolbox</span>. <span class="source" tagx="source" title="source">J Cheminform</span>. <span class="year" tagx="year" title="year">2011</span>; <span class="volume" tagx="volume" title="volume">3</span>: <span class="fpage" tagx="fpage" title="fpage">33</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/21982300">21982300</a> </span> </span> </li> <li tag="ref"> <a name="bibr36-1177932219865533" /> <span class="label" tagx="label" title="label">36</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Egbert</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Whitty</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Keseru</span> <span class="given-names" tagx="given-names" title="given-names">GM</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Vajda</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Why some targets benefit from beyond rule of five drugs</span> [published online ahead of print June 12, 2019]. <span class="source" tagx="source" title="source">J Med Chem</span>. doi: <span class="pub-id"> <a href="https://dx.doi.org/10.1021/acs.jmedchem.8b01732.">10.1021/acs.jmedchem.8b01732.</a> </span> </span> </li> <li tag="ref"> <a name="bibr37-1177932219865533" /> <span class="label" tagx="label" title="label">37</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lipinski</span> <span class="given-names" tagx="given-names" title="given-names">CA</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lombardo</span> <span class="given-names" tagx="given-names" title="given-names">F</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Dominy</span> <span class="given-names" tagx="given-names" title="given-names">BW</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Feeney</span> <span class="given-names" tagx="given-names" title="given-names">PJ.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings </span>. <span class="source" tagx="source" title="source">Adv Drug Delivery Rev</span>. <span class="year" tagx="year" title="year">2012</span>; <span class="volume" tagx="volume" title="volume">64</span>: <span class="fpage" tagx="fpage" title="fpage">4</span>– <span class="lpage" tagx="lpage" title="lpage">17</span>. </span> </li> <li tag="ref"> <a name="bibr38-1177932219865533" /> <span class="label" tagx="label" title="label">38</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Behrouz</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Rad</span> <span class="given-names" tagx="given-names" title="given-names">MN</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Shahraki</span> <span class="given-names" tagx="given-names" title="given-names">BT</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Fathalipour</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Behrouz</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Mirkhani</span> <span class="given-names" tagx="given-names" title="given-names">H.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Design, synthesis, and in silico studies of novel eugenyloxy propanol azole derivatives having potent antinociceptive activity and evaluation of their β-adrenoceptor blocking property </span>. <span class="source" tagx="source" title="source">Molec Diversity</span>. <span class="year" tagx="year" title="year">2019</span>; <span class="volume" tagx="volume" title="volume">23</span>: <span class="fpage" tagx="fpage" title="fpage">147</span>– <span class="lpage" tagx="lpage" title="lpage">164</span>. </span> </li> <li tag="ref"> <a name="bibr39-1177932219865533" /> <span class="label" tagx="label" title="label">39</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Torres</span> <span class="given-names" tagx="given-names" title="given-names">E</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Moreno</span> <span class="given-names" tagx="given-names" title="given-names">E</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ancizu</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">New 1,4-di-N-oxide-quinoxaline-2-ylmethylene isonicotinic acid hydrazide derivatives as anti-mycobacterium tuberculosis agents </span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span>. <span class="year" tagx="year" title="year">2011</span>; <span class="volume" tagx="volume" title="volume">21</span>: <span class="fpage" tagx="fpage" title="fpage">3699</span>– <span class="lpage" tagx="lpage" title="lpage">3703</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/21570839">21570839</a> </span> </span> </li> <li tag="ref"> <a name="bibr40-1177932219865533" /> <span class="label" tagx="label" title="label">40</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Daina</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Michielin</span> <span class="given-names" tagx="given-names" title="given-names">O</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zoete</span> <span class="given-names" tagx="given-names" title="given-names">V.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules </span>. <span class="source" tagx="source" title="source">Sci Rep</span>. <span class="year" tagx="year" title="year">2017</span>; <span class="volume" tagx="volume" title="volume">7</span>: <span class="fpage" tagx="fpage" title="fpage">42717</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/28256516">28256516</a> </span> </span> </li> <li tag="ref"> <a name="bibr41-1177932219865533" /> <span class="label" tagx="label" title="label">41</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lohidakshan</span> <span class="given-names" tagx="given-names" title="given-names">K</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Rajan</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ganesh</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Paul</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Jerin</span> <span class="given-names" tagx="given-names" title="given-names">J.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Pass and Swiss ADME collaborated in silico docking approach to the synthesis of certain pyrazoline spacer compounds for dihydrofolate reductase inhibition and antimalarial activity </span>. <span class="source" tagx="source" title="source">Bangladesh J Pharmacol</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">13</span>: <span class="fpage" tagx="fpage" title="fpage">23</span>– <span class="lpage" tagx="lpage" title="lpage">29</span>. </span> </li> <li tag="ref"> <a name="bibr42-1177932219865533" /> <span class="label" tagx="label" title="label">42</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Mahato</span> <span class="given-names" tagx="given-names" title="given-names">S</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Singh</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Rangan</span> <span class="given-names" tagx="given-names" title="given-names">L</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Jana</span> <span class="given-names" tagx="given-names" title="given-names">CK.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Synthesis, in silico studies and in vitro evaluation for antioxidant and antibacterial properties of diarylmethylamines: a novel class of structurally simple and highly potent pharmacophore </span>. <span class="source" tagx="source" title="source">Eur J Pharm Sci</span>. <span class="year" tagx="year" title="year">2016</span>; <span class="volume" tagx="volume" title="volume">88</span>: <span class="fpage" tagx="fpage" title="fpage">202</span>– <span class="lpage" tagx="lpage" title="lpage">209</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/26993964">26993964</a> </span> </span> </li> <li tag="ref"> <a name="bibr43-1177932219865533" /> <span class="label" tagx="label" title="label">43</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Muegge</span> <span class="given-names" tagx="given-names" title="given-names">I</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Heald</span> <span class="given-names" tagx="given-names" title="given-names">SL</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Brittelli</span> <span class="given-names" tagx="given-names" title="given-names">D.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Simple selection criteria for drug-like chemical matter</span>. <span class="source" tagx="source" title="source">J Med Chem</span>. <span class="year" tagx="year" title="year">2001</span>; <span class="volume" tagx="volume" title="volume">44</span>: <span class="fpage" tagx="fpage" title="fpage">1841</span>– <span class="lpage" tagx="lpage" title="lpage">1846</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/11384230">11384230</a> </span> </span> </li> <li tag="ref"> <a name="bibr44-1177932219865533" /> <span class="label" tagx="label" title="label">44</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ghose</span> <span class="given-names" tagx="given-names" title="given-names">AK</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Viswanadhan</span> <span class="given-names" tagx="given-names" title="given-names">VN</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Wendoloski</span> <span class="given-names" tagx="given-names" title="given-names">JJ</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases </span>. <span class="source" tagx="source" title="source">J Comb Chem</span>. <span class="year" tagx="year" title="year">1999</span>; <span class="volume" tagx="volume" title="volume">1</span>: <span class="fpage" tagx="fpage" title="fpage">55</span>– <span class="lpage" tagx="lpage" title="lpage">68</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/10746014">10746014</a> </span> </span> </li> <li tag="ref"> <a name="bibr45-1177932219865533" /> <span class="label" tagx="label" title="label">45</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Egan</span> <span class="given-names" tagx="given-names" title="given-names">WJ</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Merz</span> <span class="given-names" tagx="given-names" title="given-names">KM</span> <span class="suffix" tagx="suffix" title="suffix">Jr</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Baldwin</span> <span class="given-names" tagx="given-names" title="given-names">JJ.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Prediction of drug absorption using multivariate statistics</span>. <span class="source" tagx="source" title="source">J Med Chem</span>. <span class="year" tagx="year" title="year">2000</span>; <span class="volume" tagx="volume" title="volume">43</span>: <span class="fpage" tagx="fpage" title="fpage">3867</span>– <span class="lpage" tagx="lpage" title="lpage">3877</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/11052792">11052792</a> </span> </span> </li> <li tag="ref"> <a name="bibr46-1177932219865533" /> <span class="label" tagx="label" title="label">46</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Veber</span> <span class="given-names" tagx="given-names" title="given-names">DF</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Johnson</span> <span class="given-names" tagx="given-names" title="given-names">SR</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Cheng</span> <span class="given-names" tagx="given-names" title="given-names">HY</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Smith</span> <span class="given-names" tagx="given-names" title="given-names">BR</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ward</span> <span class="given-names" tagx="given-names" title="given-names">KW</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Kopple</span> <span class="given-names" tagx="given-names" title="given-names">KD.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Molecular properties that influence the oral bioavailability of drug candidates</span>. <span class="source" tagx="source" title="source">J Med Chem</span>. <span class="year" tagx="year" title="year">2002</span>; <span class="volume" tagx="volume" title="volume">45</span>: <span class="fpage" tagx="fpage" title="fpage">2615</span>– <span class="lpage" tagx="lpage" title="lpage">2623</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/12036371">12036371</a> </span> </span> </li> <li tag="ref"> <a name="bibr47-1177932219865533" /> <span class="label" tagx="label" title="label">47</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Pettersen</span> <span class="given-names" tagx="given-names" title="given-names">EF</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Goddard</span> <span class="given-names" tagx="given-names" title="given-names">TD</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Huang</span> <span class="given-names" tagx="given-names" title="given-names">CC</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">UCSF Chimera – a visualization system for exploratory research and analysis</span>. <span class="source" tagx="source" title="source">J Comput Chem</span>. <span class="year" tagx="year" title="year">2004</span>; <span class="volume" tagx="volume" title="volume">25</span>: <span class="fpage" tagx="fpage" title="fpage">1605</span>– <span class="lpage" tagx="lpage" title="lpage">1612</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/15264254">15264254</a> </span> </span> </li> <li tag="ref"> <a name="bibr48-1177932219865533" /> <span class="label" tagx="label" title="label">48</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Singh</span> <span class="given-names" tagx="given-names" title="given-names">IV</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Mishra</span> <span class="given-names" tagx="given-names" title="given-names">S.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Molecular docking analysis of Pyrimethamine derivatives with Plasmodium falciparum dihydrofolate reductase </span>. <span class="source" tagx="source" title="source">Bioinformation</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">14</span>: <span class="fpage" tagx="fpage" title="fpage">232</span>– <span class="lpage" tagx="lpage" title="lpage">235</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/30108420">30108420</a> </span> </span> </li> <li tag="ref"> <a name="bibr49-1177932219865533" /> <span class="label" tagx="label" title="label">49</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Tian</span> <span class="given-names" tagx="given-names" title="given-names">W</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Chen</span> <span class="given-names" tagx="given-names" title="given-names">C</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lei</span> <span class="given-names" tagx="given-names" title="given-names">X</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Zhao</span> <span class="given-names" tagx="given-names" title="given-names">J</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Liang</span> <span class="given-names" tagx="given-names" title="given-names">J.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">CASTp 3.0: computed atlas of surface topography of proteins</span>. <span class="source" tagx="source" title="source">Nucleic Acids Res</span>. <span class="year" tagx="year" title="year">2018</span>; <span class="volume" tagx="volume" title="volume">46</span>: <span class="fpage" tagx="fpage" title="fpage">W363</span>– <span class="lpage" tagx="lpage" title="lpage">W367</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/29860391">29860391</a> </span> </span> </li> <li tag="ref"> <a name="bibr50-1177932219865533" /> <span class="label" tagx="label" title="label">50</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Dundas</span> <span class="given-names" tagx="given-names" title="given-names">J</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Ouyang</span> <span class="given-names" tagx="given-names" title="given-names">Z</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Tseng</span> <span class="given-names" tagx="given-names" title="given-names">J</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Binkowski</span> <span class="given-names" tagx="given-names" title="given-names">A</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Turpaz</span> <span class="given-names" tagx="given-names" title="given-names">Y</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Liang</span> <span class="given-names" tagx="given-names" title="given-names">J.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues </span>. <span class="source" tagx="source" title="source">Nucleic Acids Res</span>. <span class="year" tagx="year" title="year">2006</span>; <span class="volume" tagx="volume" title="volume">34</span>: <span class="fpage" tagx="fpage" title="fpage">W116</span>– <span class="lpage" tagx="lpage" title="lpage">W118</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/16844972">16844972</a> </span> </span> </li> <li tag="ref"> <a name="bibr51-1177932219865533" /> <span class="label" tagx="label" title="label">51</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Toth</span> <span class="given-names" tagx="given-names" title="given-names">EA</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Yeates</span> <span class="given-names" tagx="given-names" title="given-names">TO.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">The structure of adenylosuccinate lyase, an enzyme with dual activity in the de novo purine biosynthetic pathway </span>. <span class="source" tagx="source" title="source">Structure</span>. <span class="year" tagx="year" title="year">2000</span>; <span class="volume" tagx="volume" title="volume">8</span>: <span class="fpage" tagx="fpage" title="fpage">163</span>– <span class="lpage" tagx="lpage" title="lpage">174</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/10673438">10673438</a> </span> </span> </li> <li tag="ref"> <a name="bibr52-1177932219865533" /> <span class="label" tagx="label" title="label">52</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Yang</span> <span class="given-names" tagx="given-names" title="given-names">J</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Wang</span> <span class="given-names" tagx="given-names" title="given-names">Y</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Woolridge</span> <span class="given-names" tagx="given-names" title="given-names">EM</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Crystal structure of 3-carboxy-cis, cis-muconate lactonizing enzyme from Pseudomonas putida, a fumarase class II type cycloisomerase: enzyme evolution in parallel pathways </span>. <span class="source" tagx="source" title="source">Biochemistry</span>. <span class="year" tagx="year" title="year">2004</span>; <span class="volume" tagx="volume" title="volume">43</span>: <span class="fpage" tagx="fpage" title="fpage">10424</span>– <span class="lpage" tagx="lpage" title="lpage">10434</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/15301541">15301541</a> </span> </span> </li> <li tag="ref"> <a name="bibr53-1177932219865533" /> <span class="label" tagx="label" title="label">53</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Morris</span> <span class="given-names" tagx="given-names" title="given-names">GM</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Huey</span> <span class="given-names" tagx="given-names" title="given-names">R</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lindstrom</span> <span class="given-names" tagx="given-names" title="given-names">W</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</span>. <span class="source" tagx="source" title="source">J Comput Chem</span>. <span class="year" tagx="year" title="year">2009</span>; <span class="volume" tagx="volume" title="volume">30</span>: <span class="fpage" tagx="fpage" title="fpage">2785</span>– <span class="lpage" tagx="lpage" title="lpage">2791</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/19399780">19399780</a> </span> </span> </li> <li tag="ref"> <a name="bibr54-1177932219865533" /> <span class="label" tagx="label" title="label">54</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Laskowski</span> <span class="given-names" tagx="given-names" title="given-names">RA</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Swindells</span> <span class="given-names" tagx="given-names" title="given-names">MB.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">LigPlot+: multiple ligand–protein interaction diagrams for drug discovery</span>. <span class="source" tagx="source" title="source">J Chem Inf Model</span>. <span class="year" tagx="year" title="year">2011</span>; <span class="volume" tagx="volume" title="volume">51</span>: <span class="fpage" tagx="fpage" title="fpage">2778</span>– <span class="lpage" tagx="lpage" title="lpage">2786</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/21919503">21919503</a> </span> </span> </li> <li tag="ref"> <a name="bibr55-1177932219865533" /> <span class="label" tagx="label" title="label">55</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lunin</span> <span class="given-names" tagx="given-names" title="given-names">VV</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Wernimont</span> <span class="given-names" tagx="given-names" title="given-names">AK</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Lew</span> <span class="given-names" tagx="given-names" title="given-names">J</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Plasmodium vivax adenylosuccinate lyase Pv003765 with AMP bound</span>, <a href="https://www.thesgc.org/structures/2qga">https://www.thesgc.org/structures/2qga</a> </span> </li> <li tag="ref"> <a name="bibr56-1177932219865533" /> <span class="label" tagx="label" title="label">56</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Goujon</span> <span class="given-names" tagx="given-names" title="given-names">M</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">McWilliam</span> <span class="given-names" tagx="given-names" title="given-names">H</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Li</span> <span class="given-names" tagx="given-names" title="given-names">W</span> </span> <span class="etal" title="etal"> <i>et al.</i> </span> </span> <span class="mixed-article-title" title="mixed-article-title">A new bioinformatics analysis tools framework at EMBL–EBI</span>. <span class="source" tagx="source" title="source">Nucleic Acids Res</span>. <span class="year" tagx="year" title="year">2010</span>; <span class="volume" tagx="volume" title="volume">38</span>: <span class="fpage" tagx="fpage" title="fpage">W695</span>– <span class="lpage" tagx="lpage" title="lpage">W699</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/20439314">20439314</a> </span> </span> </li> <li tag="ref"> <a name="bibr57-1177932219865533" /> <span class="label" tagx="label" title="label">57</span> <span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"> <span class="person-group'"> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Wu</span> <span class="given-names" tagx="given-names" title="given-names">CY</span> </span> <span class="name" tagx="name" title="name"> <span class="surname" tagx="surname" title="surname">Benet</span> <span class="given-names" tagx="given-names" title="given-names">LZ.</span> </span> </span> <span class="mixed-article-title" title="mixed-article-title">Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system </span>. <span class="source" tagx="source" title="source">Pharm Res</span>. <span class="year" tagx="year" title="year">2005</span>; <span class="volume" tagx="volume" title="volume">22</span>: <span class="fpage" tagx="fpage" title="fpage">11</span>– <span class="lpage" tagx="lpage" title="lpage">23</span>. <span class="pub-id"> <a href="http://www.ncbi.nlm.nih.gov/pubmed/15771225">15771225</a> </span> </span> </li> </ul> </div> </div>  </body></html>